tradingkey.logo

Cibus Inc

CBUS

1.420USD

+0.070+5.19%
終値 09/19, 16:00ET15分遅れの株価
74.52M時価総額
損失額直近12ヶ月PER

Cibus Inc

1.420

+0.070+5.19%
詳細情報 Cibus Inc 企業名
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.
企業情報
企業コードCBUS
会社名Cibus Inc
上場日Jul 20, 2017
最高経営責任者「CEO」Dr. Peter Ronald Beetham, Ph.D.
従業員数157
証券種類Ordinary Share
決算期末Jul 20
本社所在地6455 Nancy Ridge Drive
都市SAN DIEGO
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号92121
電話番号18584500008
ウェブサイトhttps://www.cibus.com/
企業コードCBUS
上場日Jul 20, 2017
最高経営責任者「CEO」Dr. Peter Ronald Beetham, Ph.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
Ms. Kimberly Ann (Kim) Box
Ms. Kimberly Ann (Kim) Box
Director
Director
--
--
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. August J. Moretti, J.D.
Mr. August J. Moretti, J.D.
Independent Director
Independent Director
--
--
Mr. Jean-Pierre Lehmann
Mr. Jean-Pierre Lehmann
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
収益内訳
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
データなし
地域別USD
会社名
収益
比率
United States
1.03M
0.00%
事業別
地域別
データなし
株主
更新時刻: Tue, Aug 19
更新時刻: Tue, Aug 19
株主統計
種類
株主統計
株主統計
比率
Riggs (Rory B)
27.84%
Fidelity Management & Research Company LLC
13.64%
JPL Investments SA
3.19%
Vantage Consulting Group, Inc.
2.18%
Gratia Capital, LLC
1.63%
他の
51.52%
株主統計
株主統計
比率
Riggs (Rory B)
27.84%
Fidelity Management & Research Company LLC
13.64%
JPL Investments SA
3.19%
Vantage Consulting Group, Inc.
2.18%
Gratia Capital, LLC
1.63%
他の
51.52%
種類
株主統計
比率
Individual Investor
30.25%
Investment Advisor
17.55%
Investment Advisor/Hedge Fund
3.28%
Corporation
3.26%
Hedge Fund
2.52%
Research Firm
0.56%
Family Office
0.21%
Bank and Trust
0.06%
他の
42.31%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
166
29.20M
60.37%
+13.40M
2025Q1
171
17.83M
39.89%
+256.22K
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Riggs (Rory B)
14.63M
30.24%
+11.68M
+396.82%
Jun 09, 2025
Fidelity Management & Research Company LLC
4.60M
9.5%
+647.11K
+16.38%
Mar 31, 2025
JPL Investments SA
1.67M
3.46%
-12.28K
-0.73%
Mar 24, 2025
Vantage Consulting Group, Inc.
1.14M
2.36%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
892.12K
1.84%
+41.63K
+4.90%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.03M
2.13%
-16.63K
-1.59%
Mar 31, 2025
Beetham (Peter Ronald)
382.44K
0.79%
--
--
Mar 24, 2025
Gocal (Gregory Francis William)
374.84K
0.77%
+60.00K
+19.06%
Mar 24, 2025
Geode Capital Management, L.L.C.
473.61K
0.98%
+81.22K
+20.70%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Tue, Sep 2
更新時刻: Tue, Sep 2
銘柄名
比率
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
比率0.01%
iShares Russell 2000 Value ETF
比率0%
Global X Russell 2000 ETF
比率0%
Proshares Ultra Russell 2000
比率0%
ProShares UltraPro Russell2000
比率0%
ProShares Hedge Replication ETF
比率0%
iShares Core S&P Total U.S. Stock Market ETF
比率0%
iShares Russell 2000 ETF
比率0%
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI